Jim Cramer on Johnson & Johnson: “Very Rare Triple-A Balance Sheet”

Company Overview - Johnson & Johnson (NYSE: JNJ) develops and sells a wide range of healthcare products, including pharmaceuticals, medical devices, and vision care [2] - The company provides treatments in various fields such as immunology, oncology, neuroscience, cardiovascular diseases, surgical technologies, orthopedics, and contact lenses [2] Stock Performance - As of the last market close, JNJ was the 10th best performing healthcare stock in the S&P 500, with a year-to-date increase of 21.5% [1] - Despite ongoing major litigation issues, JNJ's stock performance has been surprisingly strong in a market that is generally unfavorable towards pharmaceutical companies [1]